Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Single-Crystalline 3C-SiC anodically Bonded onto Glass: An Excellent Platform for High-Temperature Electronics and Bioapplications.

Phan HP, Cheng HH, Dinh T, Wood B, Nguyen TK, Mu F, Kamble H, Vadivelu R, Walker G, Hold L, Iacopi A, Haylock B, Dao DV, Lobino M, Suga T, Nguyen NT.

ACS Appl Mater Interfaces. 2017 Aug 23;9(33):27365-27371. doi: 10.1021/acsami.7b06661. Epub 2017 Aug 15.

PMID:
28792726
2.

The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.

Millward CP, Brodbelt AR, Haylock B, Zakaria R, Baborie A, Crooks D, Husband D, Shenoy A, Wong H, Jenkinson MD.

Acta Neurochir (Wien). 2016 Oct;158(10):1943-53. doi: 10.1007/s00701-016-2928-8. Epub 2016 Aug 15.

PMID:
27526690
3.

Nine-channel mid-power bipolar pulse generator based on a field programmable gate array.

Haylock B, Lenzini F, Kasture S, Fisher P, Streed EW, Lobino M.

Rev Sci Instrum. 2016 May;87(5):054709. doi: 10.1063/1.4949508.

PMID:
27250453
4.

Cell cycle progression in glioblastoma cells is unaffected by pathophysiological levels of hypoxia.

Richards R, Jenkinson MD, Haylock BJ, See V.

PeerJ. 2016 Mar 3;4:e1755. doi: 10.7717/peerj.1755. eCollection 2016.

5.

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.

Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J, Bulbeck H, Das K, Farrell M, Looby S, Hickey H, Preusser M, Mallucci CL, Hughes D, Gamble C, Weber DC.

Trials. 2015 Nov 14;16:519. doi: 10.1186/s13063-015-1040-3.

6.

Anisotropic model for the fabrication of annealed and reverse proton exchanged waveguides in congruent lithium niobate.

Lenzini F, Kasture S, Haylock B, Lobino M.

Opt Express. 2015 Jan 26;23(2):1748-56. doi: 10.1364/OE.23.001748.

PMID:
25835930
7.

Intracranial desmoplastic small round cell tumor presenting as a suprasellar mass.

Thondam SK, du Plessis D, Cuthbertson DJ, Das KS, Javadpour M, MacFarlane IA, Leggate J, Haylock B, Daousi C.

J Neurosurg. 2015 Apr;122(4):773-7. doi: 10.3171/2014.10.JNS132490. Epub 2014 Dec 5.

PMID:
25479120
8.

Atypical meningoma: current management dilemmas and prospective clinical trials.

Jenkinson MD, Weber DC, Haylock BJ, Mallucci CL, Zakaria R, Javadpour M.

J Neurooncol. 2015 Jan;121(1):1-7. doi: 10.1007/s11060-014-1620-1. Epub 2014 Sep 26. Review.

PMID:
25258253
9.

Radiotherapy versus observation following surgical resection of atypical meningioma (the ROAM trial).

Jenkinson MD, Weber DC, Haylock BJ, Mallucci CL, Zakaria R, Javadpour M.

Neuro Oncol. 2014 Nov;16(11):1560-1. doi: 10.1093/neuonc/nou149. Epub 2014 Jul 19. No abstract available.

10.

Is current technology improving outcomes with radiation therapy for gliomas?

Brada M, Haylock B.

Am Soc Clin Oncol Educ Book. 2014:e89-94. doi: 10.14694/EdBook_AM.2014.34.e89. Review.

11.

The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.

Sanghera P, Rampling R, Haylock B, Jefferies S, McBain C, Rees JH, Soh C, Whittle IR.

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):216-27. doi: 10.1016/j.clon.2011.06.004. Epub 2011 Jul 23. Review.

PMID:
21783349
12.

Gene expression in oligodendroglial tumors.

Shaw EJ, Haylock B, Husband D, du Plessis D, Sibson DR, Warnke PC, Walker C.

Cell Oncol (Dordr). 2011 Aug;34(4):355-67. doi: 10.1007/s13402-011-0036-6. Epub 2011 May 31.

PMID:
21625997
13.

Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.

Gollins S, Sun Myint A, Haylock B, Wise M, Saunders M, Neupane R, Essapen S, Samuel L, Dougal M, Lloyd A, Morris J, Topham C, Susnerwala S.

J Clin Oncol. 2011 Mar 10;29(8):1042-9. doi: 10.1200/JCO.2010.29.7697. Epub 2011 Jan 24.

PMID:
21263095
14.

Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy.

Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M.

Eur J Cancer. 2011 Mar;47(5):649-55. doi: 10.1016/j.ejca.2010.11.033. Epub 2010 Dec 31. Review.

PMID:
21196112
15.

Gene expression in oligodendroglial tumors.

Shaw EJ, Haylock B, Husband D, du Plessis D, Sibson DR, Warnke PC, Walker C.

Anal Cell Pathol (Amst). 2010;33(2):81-94. doi: 10.3233/ACP-CLO-2010-0533. Erratum in: Cell Oncol (Dordr). 2011 Aug;34(4):407-8.

16.

Molecular genetics, imaging and treatment of oligodendroglial tumours.

Jenkinson MD, Walker C, Brodbelt AR, Wilkins S, Husband D, Haylock B.

Acta Neurochir (Wien). 2010 Nov;152(11):1815-25. doi: 10.1007/s00701-010-0784-5. Epub 2010 Sep 2. Review.

PMID:
20811757
17.

Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.

Jenkinson MD, Smith TS, Haylock B, Husband D, Shenoy A, Vinjamuri S, Walker C, Pietronigro D, Warnke PC.

J Neurooncol. 2010 Aug;99(1):103-13. doi: 10.1007/s11060-010-0113-0. Epub 2010 Jan 10.

PMID:
20063175
18.

Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).

Gollins SW, Myint S, Susnerwala S, Haylock B, Wise M, Topham C, Samuel L, Swindell R, Morris J, Mason L, Levine E.

Br J Cancer. 2009 Sep 15;101(6):924-34. doi: 10.1038/sj.bjc.6605258. Epub 2009 Aug 18.

19.

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.

Dunn J, Baborie A, Alam F, Joyce K, Moxham M, Sibson R, Crooks D, Husband D, Shenoy A, Brodbelt A, Wong H, Liloglou T, Haylock B, Walker C.

Br J Cancer. 2009 Jul 7;101(1):124-31. doi: 10.1038/sj.bjc.6605127. Epub 2009 Jun 16.

20.

Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study.

Iles S, Gollins S, Susnerwala S, Haylock B, Myint S, Biswas A, Swindell R, Levine E.

Br J Cancer. 2008 Apr 8;98(7):1210-6. doi: 10.1038/sj.bjc.6604292. Epub 2008 Mar 18.

21.

Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.

Walker C, Haylock B, Husband D, Joyce KA, Fildes D, Jenkinson MD, Smith T, Broome J, Kopitzki K, du Plessis DG, Prosser J, Vinjamuri S, Warnke PC.

Br J Cancer. 2006 Nov 20;95(10):1424-31. Epub 2006 Oct 10.

22.

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

Jenkinson MD, Smith TS, Joyce KA, Fildes D, Broome J, du Plessis DG, Haylock B, Husband DJ, Warnke PC, Walker C.

Neuroradiology. 2006 Oct;48(10):703-13. Epub 2006 Aug 26.

23.

Expression of survivin, platelet-derived growth factor A (PDGF-A) and PDGF receptor alpha in primary central nervous system lymphoma.

Karabatsou K, Pal P, Dodd S, Mat A, Haylock B, Aguirreburualde M, Moxam N, Pinson-Ellis W, Broome J, Rainov NG.

J Neurooncol. 2006 Sep;79(2):171-9. Epub 2006 Jul 19.

PMID:
16850112
24.

Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.

Walker C, Haylock B, Husband D, Joyce KA, Fildes D, Jenkinson MD, Smith T, Broome J, du Plessis DG, Warnke PC.

Neurology. 2006 Jun 13;66(11):1661-7.

PMID:
16769937
25.

Molecular pathology and clinical characteristics of oligodendroglial neoplasms.

Walker C, du Plessis DG, Joyce KA, Fildes D, Gee A, Haylock B, Husband D, Smith T, Broome J, Warnke PC.

Ann Neurol. 2005 Jun;57(6):855-65.

PMID:
15929038
26.

Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.

Walker C, du Plessis DG, Fildes D, Haylock B, Husband D, Jenkinson MD, Joyce KA, Broome J, Kopitski K, Prosser J, Smith T, Vinjamuri S, Warnke PC.

Clin Cancer Res. 2004 Nov 1;10(21):7182-91.

27.

Does nursing need a definition of its role.

Haylock B.

Br J Nurs. 2002 Dec 12-2003 Jan 8;11(22):1428. No abstract available.

PMID:
12516626
28.

Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy.

Haylock BJ, Coppin CM, Jackson J, Basco VE, Wilson KS.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):355-62.

PMID:
10661342
29.

Stage I endometrial carcinoma: the role of neoadjuvant progesterone therapy.

Haylock BJ, Murrell DS, Bourne H, Acworth P.

Clin Oncol (R Coll Radiol). 1993;5(2):102-6.

PMID:
8481358
30.

Primary radiotherapy for subglottic carcinoma.

Haylock BJ, Deutsch GP.

Clin Oncol (R Coll Radiol). 1993;5(3):143-6.

PMID:
8347536
31.

The treatment of squamous cell carcinoma of the paranasal sinuses.

Haylock BJ, John DG, Paterson IC.

Clin Oncol (R Coll Radiol). 1991 Jan;3(1):17-21.

PMID:
1705815
32.

OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.

Maughan TS, Haylock B, Hayward M, Facey P, Evans WD, Shelley MD, Fish RG, Adams M.

Clin Oncol (R Coll Radiol). 1990 Jul;2(4):199-205.

PMID:
2261415

Supplemental Content

Loading ...
Support Center